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Introduction
Peripheral artery disease (PAD) comprises atherosclerosis of
abdominal aorta, iliac and lower extremity artery is an under
diagnosed, undertreated and poorly understood entity which
is much more common than previously thought.1 Patients
with PAD experience many problems such as claudication,
ischaemic rest pain, ischaemic ulcerations, repeated
hospitalisations, revascularisations, and limb loss.1 This leads
to poor quality of life and a high rate of depression.1 They also
have a greater likelihood of experiencing a myocardial
infarction (MI), stroke and cardiovascular death, and have a
higher rate of all-cause mortality compared with the patients
without PAD.1 Approximately 12% of the adult population
has PAD, and the prevalence is equal in men and women.1
Almost 20% of adults older than 70 years of age have PAD.1
The most common risk factors associated with PAD are
increasing age, diabetes, and smoking.1 The prevalence of
PAD was seen to be 4.3% in patients aged more than 40 years
compared with 14.5% in those older than 70 years.1
Of all the non-invasive methods for the diagnosis of PAD,
the ankle brachial index (ABI), segmental analysis and
pulse volume waveform analysis are the only techniques
that provide physiologic information about perfusion in
the limb. The ABI is an assessment of PAD and an indicator
of generalised atherosclerosis.2-4 A low ABI is associated
with increased mortality and risk of MI and stroke in the
general population, independent of conventional vascular
risk factors and prevalent cardiovascular disease.2-4 Recent
evidence suggests that measurement of the ABI may
improve the accuracy of cardiovascular risk prediction
beyond traditional risk factors in the general population.2,3
In patients with ischaemic stroke or transient ischaemic
attack (TIA), co-existing symptomatic PAD is a powerful
predictor of long-term cardiovascular risk and mortality.2
Yet the prognostic value of low ABI, which is also a highly
specific and sensitive test for asymptomatic PAD, has not
been established in the population. Two studies reported a
high prevalence of low ABI among patients with acute
ischaemic stroke or TIA, ranging from 34%2,5 to 51%.2,6
Duplex ultrasonography is a safe (no radiation or contrast
agent) and cost-effective method of accurately
determining the severity and location of stenosis and
differentiating stenosis from occlusion.1 B-mode or gray-
scale imaging is a 2-dimensional image of the artery wall
and the lumen, permitting a rough evaluation of the lesion
and atheroma characteristics. Colour flow Doppler and
pulsed wave Doppler allow an estimation of the stenosis
severity on the basis of Doppler-derived velocity criteria.1
Carotid artery stenosis (CAS) is defined as narrowing of the
common and internal carotid arteries. Between 5%
and10% of the general population aged over 65 years has
an asymptomatic CAS of 50% or greater.7 The prevalence of
asymptomatic CAS 50% or greater was highest in patients
with PAD. The degree of asymptomatic CAS is related to
various vascular risk factors, including age, smoking,
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systolic blood pressure, and cholesterol.7 A higher degree
of asymptomatic CAS was predictive for future stroke in
patients with large or small vessel atherosclerotic disease.7,8
This study was conducted to determine the ABI in patients
with acute ischaemic stroke and its association with CAS.
ABI and CAS are strong predictors of PAD, which predicts
the vascular risk, morbidity and mortality. This will help us
in strengthening primary and secondary prevention in
patients of acute ischaemic stroke with PAD.
Patients and Methods
This cross-sectional study was conducted in the
neurology section, department of medicine, Abbasi
Shaheed Hospital, Karachi Medical and Dental College,
Karachi, from July 2011 to May 2014. All patients with
ischaemic stroke aged 15 years or above of either gender
were included. Patients with an intracranial bleed or a
sub-arachnoid haemorrhage and with end-stage renal
disease (ESRD) were excluded.
After a detailed history and a complete systemic
examination, all patients included underwent the
following investigations: urea creatinine electrolytes (to
exclude patients with ESRD), electrocardiogram, and
computed tomography (CT) of brain without contrast (to
exclude patients with intracranial or sub-arachnoid
haemorrhage), carotid Doppler ultrasound, and ankle
brachial index. The following investigations were
completed according to the patient's requirement:
echocardiogram, CT, angiography, etc. 
Ankle and brachial systolic blood pressures were measured
at baseline with a mercury sphygmomanometer and a
high-frequency linear 7 MHz probe (Toshiba Xario) with the
subject in the supine position after a five-minute rest.
According to the American Heart Association's (AHA)
recommendations,2 the ABI was calculated as the ratio of
the higher of the systolic pressures in the posterior tibial or
dorsalis pedis artery and average of the right and left
brachial artery pressures (in the case of discrepancy of >10
mm Hg between the arms, the higher reading was used).
This method has been shown to result in the most accurate
estimation of peripheral artery disease. ABI was calculated
separately for each leg, and the lower of the two ABI values
was used for analysis. In accordance with the transatlantic
intersociety consensus for the management of peripheral
artery disease2 and previous studies in patients with stroke,
ABI values of <0.9 were defined as low. Patients were
diagnosed and labelled as having PAD if the ABI was <0.9.
Ultrasound examinations were performed by well-trained
and certified ultrasonologists at the department of
radiology. The degree of the CAS at both sides was assessed
with colour Doppler-assisted duplex scanning. The severity
of CAS was evaluated on the basis of the blood flow
velocity patterns. The greatest stenosis observed on the
right or the left side of the common or the internal carotid
artery was taken to determine the severity of carotid artery
disease. Accordingly, all patients were classified into one of
the following categories: absence of stenosis; mild stenosis
(<50% diameter stenosis), moderate stenosis (>50% to 69%
diameter stenosis), severe stenosis (>70% to 99% diameter
stenosis) and occlusion (100% diameter stenosis, no flow).7
North American Symptomatic Carotid Endarterectomy
Trial(NASCET) and European Carotid Surgery Trial(ECST) are
the international criteria used for symptomatic CAS.8
However, the above criteria are for asymptomatic carotid
artery stenosis. Stroke patients were classified as stated by
the Asian Stroke Criteria (ASC) for classification of brain
infarction (Table-1).9
The primary outcome measures were carotid artery
stenosis and ankle-brachial index. The other independent
variables were age (which was estimated by national
identity card; if the national identity card was not available
then it was estimated through major events of the world
like the Second World War or freedom of Pakistan), gender,
body mass index ([BMI] is a simple index of weight-for-
height that is commonly used to classify underweight,
overweight and obesity in adults. It is defined as the weight
in kilograms divided by the square of the height in metres
(kg/m2). Normal range in adult Asian population is 18-22.9,
overweight is 23-26.9 and obesity is >27), waist
circumference, as stated by International Diabetes
Federation, was measured in a horizontal plane, midway
between the inferior margin of the ribs and the superior
border of the iliac crest. Specific values for females >80cm
and for males >90cm were defined as central obesity.10
The patients were followed up on phone after six months
of presenting to the hospital. The outcome variables were
death or mortality, morbidity, or complete recovery.
Statistical analysis was performed using SPSS 20. Data was
expressed as mean, standard deviation (SD), odds ratio
(OR) and 95% confidence interval (CI) or as proportions.
The association between the independent factors and
outcome i.e. ABI for a categorical response variable with
two outcomes was assessed initially employing binary
logistic regression (one independent variable being
analysed for a single-dependent variable with categorical
response of two outcomes). Following this, a
parsimonious model was developed using multivariable
regression (more than one independent variable being
analysed for a single-dependent variable) to select, from
the identified candidate variables, a subset of variables
that were independently associated with ABI. The odds
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ratios and associated 95 per cent confidence intervals for
variables in the final model were reported. The
significance level for the binary logistic regression analysis
was p<0.25 and for multivariable regression model was
set at p<0.05. 
Results
A total of 327 patients were enrolled. Of the total stroke
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Table-1: Asian Stroke Criteria for Classification of Brain Infarction (Topographical Classification).
Large Vessel Territory (LVT)
Probable either A or B A. New cortical signs (aphasia, agnosia, apraxia, sensory neglect, visual neglect, seizure, hemianopsia)
B. MRI/CT show a new cortical lesion compatible with stroke manifestations* and /or a new lesion >2cm (If negative repeated MRI/CT >48 hours post event
recommended)
Definite both A and B A. New cortical signs (aphasia, agnosia, apraxia, sensory neglect, visual neglect, seizure, hemianopsia)
B. MRI/CT show a new cortical lesion compatible with stroke manifestations* and /or a new lesion >2cm (If negative repeated MRI/CT >48 hours post event
recommended)
Small Vessel Territory (SVT)
Probable either A or B A. Lacunar syndrome (pure motor hemiparesis, pure sensory stroke, mixed sensorimotor, ataxic hemiparesis, dysarthria clumsy hand) without new cortical
signs
B. MRI/CT performed > 48 h post event show new subcortical lesion < 2 cm*, no new cortical lesion* and no new lesion > 2 cm*
Definite both A and B A. Lacunar syndrome (pure motor hemiparesis, pure sensory stroke, mixed sensorimotor, ataxic hemiparesis, dysarthria clumsy hand) without new cortical signs
B. MRI/CT performed > 48 h post event show new subcortical lesion < 2 cm*, no new cortical lesion* and no new lesion > 2 cm*
Note: If there is new clinical or imaging evidence* of LVT, patient should be classified as LVT, regardless of new SVT evidence.  In brain stem imaging, new lesion* < 1.5 cm is considered SVT.
MRI: Magnetic resonance imaging. CT: Computed tomography.
Table-2: Association of Independent Factors to Atherosclerosis (ABI).
Total ABI < 0.9 ABI > 0.9 Unadjusted OR p-value
n=327(%) n=60(%) n=267(%) (95% CI)
Age (years)
<55 148 (45.3) 24 (40) 124 (46) 0.77 (0.43-1.3) 0.37
>55 179 (54.7) 36 (60) 143 (54)
Gender 
Male 168 (51.4) 36 (60) 132 (49) 1.53 (0.87-2.71) 0.14*
Female 159 (48.6) 24 (40) 135 (51)
BMI
Normal 168 (51.4) 33 (55) 135 (51)
Overweight 131 (40.1) 19 (32) 112 (42) 0.97(0.63-1.49) 0.88
Obese 28 (8.6) 8 (13) 20 (7)
WC 
Normal 200 (61.2) 41 (68) 159 (60) 0.68(0.38-1.24) 0.21*
Obese 127 (38.8) 19 (32) 108 (40)
DM 189 (57.8) 35 (58) 154 (58) 1.03(0.58-1.81) 0.93
HTN 300 (91.7) 49 (82) 251 (94) 0.28 (0.12-0.65) 0.003*
IHD 80 (24.5) 9 (15) 71 (27) 0.49 (0.23-1.04) 0.06*
Hyperlipidaemia 61 (18.7) 9 (15) 52 (19) 0.73(0.34-1.58) 0.42
Smoking 56 (17.1) 12(20) 44 (16) 1.27(0.62-2.58) 0.51
CHF 6 (1.8) 0 (0) 6 (2) 0.7 (0.25-1.03) 0.9
h/o Stroke 50 (15.3) 8 (13) 42 (16) 0.82(0.36-1.86) 0.64
Carotid Bruit 27 (8.3) 7 (12) 20 (7) 1.63(0.65-4.05) 0.29
Cardiac Murmurs 29 (8.9) 6 (10) 23 (9) 1.18(0.46-3.03) 0.73
CAS
Mild (<50%) 182 (55.7) 32 (53) 150 (56)
Moderate (50-69%) 140 (42.8) 25 (42) 115 (43) 0.82(0.49-1.34) 0.42
Severe (70-89%) 3 (0.9) 3 (5) 0 (0)
Occlusion (100%) 2 (0.6) 0 (0) 2 (1)
*Is used for significant variables at p<0.25
ABI: Ankle brachial index. BMI: Body mass index. OR: Odds ratio. CI: Confidence interval. WC: Waist circumference. DM: Diabetes mellitus. HTN: Hypertension. IHD: Ischaemic heart disease.
CHF: Congestive heart failure. CAS: Carotid artery stenosis.
cases, 245(75%) were definite large vessel territory,
55(17%) were probable large vessel territory stroke,
17(5%) cases were of definite small vessel territory stroke,
while 10(3%) strokes were probable small vessel territory
(Table-1).
The overall mean age was 57.64±12.8 years (range: 30-100
years). Besides, 168(51.4%) were males and 159(48.6%)
were females. ABI < 0.9 was found in 60(18%) subjects and
only 11(3%) patients had symptomatic PAD. 
Of the patients having PAD (ABI< 0.9), 24(40%) were less
than or equal to 55 years of age and 36(60%) were more
than 55 years of age. Moreover, 36(60%) were males and
24(40%) were females, whereas 33(55%) had normal BMI,
19(32%) were overweight and 8(13%) were obese.
Also, 41(68%) of them had normal waist circumference,
19(32%) were obese, 35(58%) were diabetics, 49(82%)
were hypertensive and 9(15%) had experienced
ischaemic heart disease (IHD). CAS was divided into mild,
moderate, severe and complete occlusion. In patients
with PAD, 32(53%) suffered from mild, 25(42%) with
moderate and 3(5%) patients having severe carotid artery
stenosis (Table-2).
Four variables were found to be associated significantly
with ABI: gender, waist circumference (WC), hypertension
(HTN) and IHD (p<0.25 each). More than one independent
variable was analysed in the same model for a single
outcome, i. e. ABI.  In addition to gender, WC, HTN and IHD
variables, a further five statistically non-significant
variables, including age, gender, dyslipidaemia, diabetes,
PAD and smoking, were added due to their possible
clinical association with the ABI. One variable was
identified which was independently associated with ABI
using multivariable analysis. Hypertensive was three
times more likely to have PAD/ABI compared to non-
hypertensive (OR 3.13; 95% CI for OR: 1.36-7.2; p= 0.007). 
Total mortality was observed among 72(22%) patients,
morbidity among 38(12%), 163(50%) patients completely
recovered and 54(16.5%) had lost to follow-up. In patients
with an ABI<0.9, mortality was seen in 17(30%) patients,
morbidity in 6(10%), complete recovery in 30(50%) and
7(10%) were lost to follow-up (Table-3).
Discussion 
To our knowledge, this was the first study showing
frequency of peripheral artery disease in ischaemic stroke
in Pakistan. In this cross-sectional, hospital-based study,
ankle brachial index was used to determine the presence
and absence of PAD. A total of 327 patients were enrolled
with a mean age of 57.6±12.8 years. PAD was found in
18% of the individuals with ischaemic stroke. These results
were comparable to the findings of three recent studies
that reported PAD prevalence in patients with stroke. In a
German epidemiological trial on ABI11,12 the prevalence of
ABI <0.9 was 18% in a total sample of 6,880 unselected
primary care patients and 30% in 607 patients with a
history of stroke. The Italian post-operative analgesic
therapy observational survey (PATHOS) study5 examined
1,758 patients admitted in one of 49 hospital
departments for acute coronary syndromes (57%), acute
ischaemic stroke (29%) or TIA (14%), the prevalence of ABI
<0.9 was 34% among 755 patients with stroke or TIA. In
the Scala study13 the prevalence of ABI <0.9 was higher at
51% among 852 patients with stroke or TIA admitted to 85
stroke units across Germany. This higher prevalence may
partly be explained by a higher mean age and a higher
proportion of patients with atherosclerotic stroke in
Scala.13 Busch et al. reported an ABI <0.9 in 31%
participants, of whom 29% had a history of PAD.2 A
Japanese study reported a prevalence of PAD of 17%, had
analysed 58 retrospectively selected patients with
ischaemic stroke,14 which was similar to our study.
Topakian et al.15 stated a prevalence of PAD of 45%.
We found that PAD was more in patients above 55 years of
age but there was no significant difference between the
two age groups. Similarly, Busch et al.2 and Topakian et
al.15 reported that the prevalence of PAD was seen in older
age groups with a mean age of 69.5±12.1 years.15 A study
conducted in Korea showed a prevalence of PAD in stroke
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Table-3: Follow-up Status of Patients - n (%).
Total n=327(%) ABI < 0.9 n=60 (%) ABI > 0.9 n=267 (%) X2 P-
value
Patients Follow-up 0.47
Death 72(22) 17(30) 55(21)
Disabled 38(11.6) 6(10) 32(12)
Functional Independence 163(49.8) 30(50) 133(50)
Lost to FU 54(16.5) 7(10) 47(17)
ABI: Ankle brachial index
FU: Follow-up.
of 35% and were seen in older age groups (mean age
69.9±8.7 years).16
In this study, among 60 cases having PAD more than half
had a normal BMI. Tiosan et al.17 demonstrated that
increased baseline obesity is associated with the
development of new-onset high ABI measurements over
a mean four year follow-up. In a total of 327 cases of
stroke, the majority had mild carotid stenosis, followed by
moderate stenosis. In patients with PAD a similar
proportion had mild and moderate carotid stenosis.
Topakian et al.15 stated that ABI of <0.9 was significantly
associated with a presence of carotid stenosis of >50%. 
In our study an ABI <0.9 was associated with hypertension
and diabetes, though hypertension and diabetes both
were found to be the commonest risk factors respectively.
On the contrary, ABI of <0.9 was associated with
hypertension diabetes mellitus and congestive heart
failure (CHF) as stated by Topakian et al.15
The total mortality after a period of 6 months was 22%,
morbidity was 12%. In the SCALA study an increased risk
of recurrent stroke or cardiovascular death during a mean
follow-up of 17.5 months was seen in patients with a low
ABI.6 Tanaka et al. reported that not only a low ABI but a
borderline ABI was independently associated with a
higher incidence of all-cause death, cardiovascular death,
and cardiovascular events, cardiovascular risk factors
including smoking, diabetes, hypertension and total
cholesterol even after adjustment for various
cofactors.18,19
Pathological effects of abnormal ABI have been derived
from the endothelial dysfunction, which is the initial step
of atherosclerosis,19 and is a predictor of not only
cardiovascular events but also the development of heart
failure (HF).20 Kajikawa et al.21 reported that even in
subjects with borderline ABI significant endothelial
dysfunction can be observed. A meta-analysis identified
11 studies (5,374 patients) that were not significantly
heterogeneous. Pooling-adjusted hazard ratios showed
that low ABI was associated with both an increased
hazard of recurrent stroke (hazard ratio, 1.70; 95%
confidence interval, 1.10-2.64) and an increased risk of
vascular events or vascular death (hazard ratio, 2.22; 95%
confidence interval, 1.67-2.97).22 Clinical practitioners
should be familiar with the ABI measurement and utilise
the ABI to detect and treat PAD patients early.
Our study had several limitations. It lacked follow-up,
hence predictive value of low ABI in terms of future risk of
atherothrombotic events such as recurrent stroke, angina,
myocardial infarction, death or disability is not known. No
data was systematically collected on the incidence of
recurrent stroke during or after a hospital stay. The
patients underwent a one-time measurement of ABI to
diagnose PAD during the hospital stay. However, ABI is a
reliable tool but there is some evidence suggesting
repeated measurements over time may be preferable.18
Conclusion
Abnormally low ABI suggesting subclinical PAD was 18%.
Large longitudinal studies are required to confirm
whether information on ABI needs to optimise its role in
secondary prevention of certain subgroups.
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Academy of Neurology meeting in 2014.
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